Table 4.
Prognosis of patients who developed more severe pancreatitis or not.
Total patients (n=602) | MSAP or SAP develop (n=74) | Still with MAP (n=528) | P | |
---|---|---|---|---|
Hospital duration (days) | 10±4 | 21±5 | 8±3 | .022 |
Mortality (n, %) | 4 (0.66%) | 4 (5.4%) | 0 | .015 |
ICU transfer | 20 (3.32%) | 20 (27.0%) | 0 | <.001 |
P value: “Progression to MSAP or SAP group” versus “MAP only group”.